Product Detail
SCH 500946-d3
Stable Isotope Reagent
Stock Status: Enquire
Live
For Research & Analytical Purposes. Not for Personal use.
Category
Stable Isotope Reagent
API Family
--
Storage
Refer MSDS for complete information.
Hazard Information
Refer MSDS for complete information.
SCH 500946-d3 Product Information
SCH 500946-d3 is listed under Stable Isotope Reagent. It is associated with - and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-103541.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight, stock enquiry details and supporting documentation.
Technical Data
Product Name
SCH 500946-d3
CAS No.
405057-33-2(unlabelled)
CAT No.
CS-T-103541
Molecular Formula
C₂₀H₂₀D₃F₂N₃O₃S
Molecular Weight
426.5
Category
API Family
Storage Condition
Refer MSDS for complete information.
IUPAC Name
3-(3',5'-Difluoro-[1,1'-biphenyl]-4-yl)-1-methyl-1-(1-(methylsulfonyl)piperidin-4-yl)urea-d3
Hazard Compound
Refer MSDS for complete information.
Description
Overview
SCH 500946-d3 is an isotopically labelled analog of SCH 500946 (S199030), a compound that has been studied for its activity as a pseudo-irreversible non-peptide antagonists of the neuropeptide Y (NPY) Y5 receptor, which is involved in central regulation of appetite and a target in treating obesity, hyperphagia, type II diabetes, insulin resistance, and hypertension.
Synonyms
3-(3',5'-Difluoro-[1,1'-biphenyl]-4-yl)-1-methyl-1-(1-(methylsulfonyl)piperidin-4-yl)urea-d3
Application Notes
SCH 500946-d3 is an isotopically labelled analog of SCH 500946 (S199030), a compound that has been studied for its activity as a pseudo-irreversible non-peptide antagonists of the neuropeptide Y (NPY) Y5 receptor, which is involved in central regulation of appetite and a target in treating obesity, hyperphagia, type II diabetes, insulin resistance, and hypertension.
References
Greenlee, W., et. al.: PCT Int. Appl. 101 pp. Paten (2002);Greenlee, W., et. al.: U.S. Pat. Appl. Publ. 108 pp. Patent (2003);Hesk, D., et. al.: J. Label. Compd. Radiopharm., 61, 533 92018)
